Scientific method

Vect-Horus to Take Part in a Roundtable Discussion at Viva Technology Conference

Retrieved on: 
화요일, 5월 7, 2024
Brain, Scientific method, Ionis Pharmaceuticals, Pancreatic cancer, Glioblastoma, Novo Nordisk, Viva Technology, Clinical trial, CNRS, Cancer, Biotechnology, Pharmaceutical industry

For this event, France’s National Center for Scientific Research (CNRS) has decided to highlight 10 start-ups developing disruptive technologies.

Key Points: 
  • For this event, France’s National Center for Scientific Research (CNRS) has decided to highlight 10 start-ups developing disruptive technologies.
  • In the field of Health, Vect-Horus has been selected to present its VECTrans® technology, unique in Europe, which represents a breakthrough innovation in drug targeting to the brain and other pathological tissues (e.g.
  • Vect-Horus Chief Scientific Officer Jean-Manuel Pean will take part in a roundtable, where he will present an overview of the Company and its pipeline.
  • More details on the definite roundtable program will be announced closer to the event.

Artmarket.com: CIHA Lyon 2024 - France. Artprice is an active sponsor of the International Congress of Art History (CIHA) which this year will be attended by a thousand researchers from over 70 countries

Retrieved on: 
화요일, 5월 7, 2024
Grenoble Alpes University, Le Puy-en-Velay, Partnership, Library, Sheela Gowda, Human, Speech, History, Le Corbusier, CIHA, INHA, Digital technology, Congress, Museum, Scientific method, Samuel Henry Kress, World Heritage Site, Ferdinand Cheval, Committee, Congress Center, Utrecht University, EHESS, Clothing, Firminy, University of Aberdeen, Materiality, ARC, Publication, Heart, Collection, CFHA, Dixit, Foreign Affairs, Abode of Chaos, Trade, Perception, Artifact, Circle, Contemporary Art Museum, University, Michelin, Ministry, UNESCO, Painting, Getty Foundation, Tourism

For France, which is hosting the 2024 Olympic Games in Paris, the CIHA will rank among the country's major events of the year.

Key Points: 
  • For France, which is hosting the 2024 Olympic Games in Paris, the CIHA will rank among the country's major events of the year.
  • With participants from over 70 countries and more than 1000 speakers, this year's CIHA will be a superb intellectual complement to the 2024 Olympic Games in Paris.
  • And, considering Artprice's contribution to Art History by enhancing art market transparency, their support of this Congress is a great honor and makes perfect sense.
  • The CIHA Lyon 2024 Congress is open to anyone interested in art, Art History and cultural heritage.

Artmarket.com: CIHA Lyon 2024 - France. Artprice is an active sponsor of the International Congress of Art History (CIHA) which this year will be attended by a thousand researchers from over 70 countries

Retrieved on: 
화요일, 5월 7, 2024
Grenoble Alpes University, Le Puy-en-Velay, Partnership, Library, Sheela Gowda, Human, Speech, History, Le Corbusier, CIHA, INHA, Digital technology, Congress, Museum, Scientific method, Samuel Henry Kress, World Heritage Site, Ferdinand Cheval, Committee, Congress Center, Utrecht University, EHESS, Clothing, Firminy, University of Aberdeen, Materiality, ARC, Publication, Heart, Collection, CFHA, Dixit, Foreign Affairs, Abode of Chaos, Trade, Perception, Artifact, Circle, Contemporary Art Museum, University, Michelin, Ministry, UNESCO, Painting, Getty Foundation, Tourism

For France, which is hosting the 2024 Olympic Games in Paris, the CIHA will rank among the country's major events of the year.

Key Points: 
  • For France, which is hosting the 2024 Olympic Games in Paris, the CIHA will rank among the country's major events of the year.
  • With participants from over 70 countries and more than 1000 speakers, this year's CIHA will be a superb intellectual complement to the 2024 Olympic Games in Paris.
  • And, considering Artprice's contribution to Art History by enhancing art market transparency, their support of this Congress is a great honor and makes perfect sense.
  • The CIHA Lyon 2024 Congress is open to anyone interested in art, Art History and cultural heritage.

Think tank report highlights China's approach to modernization

Retrieved on: 
일요일, 5월 5, 2024
Scientific method, CPC, Way Forward, Thought, Communist party, Literature, Central committee, Speech, Xinhua News Agency, Family, CNRS, Management

PARIS, May 4, 2024 /PRNewswire/ -- A report released by Chinese think tanks here on Saturday introduced the process of Chinese modernization and highlighted its global significance.

Key Points: 
  • PARIS, May 4, 2024 /PRNewswire/ -- A report released by Chinese think tanks here on Saturday introduced the process of Chinese modernization and highlighted its global significance.
  • The report, entitled "Chinese Modernization: the Way Forward," was co-authored by researchers from the Institute of Party History and Literature of the Central Committee of the Communist Party of China (CPC), and Xinhua Institute, which is a high-end think tank of Xinhua News Agency.
  • The Chinese people, under the CPC's leadership, have blazed a trail of Chinese modernization, said Fu Hua, president of Xinhua News Agency and also chairman of the academic committee of Xinhua Institute.
  • Chinese President Xi Jinping, by elaborating on the connotation and essence of Chinese modernization, has contributed major innovations to global modernization theories, Fu said.

Siri's First Head of Product and Design Launches Proemial, a New AI Startup Combating Misinformation

Retrieved on: 
월요일, 4월 29, 2024
Software, Networks, Internet, Social Media, Search Engine Optimization, Search Engine Marketing, Data Management, Technology, Artificial Intelligence, Marketing, Audio, Video, Communications, Education, CERN, Scientific method, Meta-analysis, ChatGPT, Policy, Publication, AI, Diabetes, Meta, Preface, Research, Life, Alphabet, Human, Plague, Cornell University, Novo Nordisk, Science, Siri, Multimedia, Paper, Organization, Knowledge, MIT

Siri’s first Head of Product and Design, Mads Rydahl, has funneled his extensive knowledge of AI and Large Language Models (LLMs) into a new company; Proemial .

Key Points: 
  • Siri’s first Head of Product and Design, Mads Rydahl, has funneled his extensive knowledge of AI and Large Language Models (LLMs) into a new company; Proemial .
  • View the full release here: https://www.businesswire.com/news/home/20240429945823/en/
    Based in Aarhus, Denmark, Proemial is founded by (from left) tech veteran Brian Pedersen, serial entrepreneur Geet Khosla, and Mads Rydahl, Siri's first Head of Product and Design.
  • proem adapts to users’ language style without sacrificing insight and without resorting to misleading info that plague some AI tools’ output.
  • The solutions to some of our biggest problems are being solved in research papers that nobody reads - until now.”

Hyperspectral Imaging Systems Market worth $1,359 million by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
수요일, 4월 17, 2024
Environmental monitoring, Investment, Laboratory, Diagnosis, Defense, Monitoring, Scientific method, Near, Corning Inc., Mercury cadmium telluride, Infrared, MWIR, Automation, Statistics, SWIR, Indium arsenide, Research, Cooling, Hyperspectral imaging, Agriculture, Mobile device, Shortwave radio, Acquisition, Anomaly, Security, LWIR, Food, Row, Medical imaging

Based on application type, the hyperspectral imaging systems market for research & diagnostics is expected to hold the highest CAGR during the forecast period.

Key Points: 
  • Based on application type, the hyperspectral imaging systems market for research & diagnostics is expected to hold the highest CAGR during the forecast period.
  • Hyperspectral imaging systems market for visible & NIR by wavelength to hold the highest market share during the forecast period.
  • North America, in the hyperspectral imaging systems market, is expected to exhibit the highest market share during the forecast period.
  • Due to several key factors, the North American region is expected to hold the highest market share in the hyperspectral imaging systems industry .

Hyperspectral Imaging Systems Market worth $1,359 million by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
수요일, 4월 17, 2024
Environmental monitoring, Investment, Laboratory, Diagnosis, Defense, Monitoring, Scientific method, Near, Corning Inc., Mercury cadmium telluride, Infrared, MWIR, Automation, Statistics, SWIR, Indium arsenide, Research, Cooling, Hyperspectral imaging, Agriculture, Mobile device, Shortwave radio, Acquisition, Anomaly, Security, LWIR, Food, Row, Medical imaging

Based on application type, the hyperspectral imaging systems market for research & diagnostics is expected to hold the highest CAGR during the forecast period.

Key Points: 
  • Based on application type, the hyperspectral imaging systems market for research & diagnostics is expected to hold the highest CAGR during the forecast period.
  • Hyperspectral imaging systems market for visible & NIR by wavelength to hold the highest market share during the forecast period.
  • North America, in the hyperspectral imaging systems market, is expected to exhibit the highest market share during the forecast period.
  • Due to several key factors, the North American region is expected to hold the highest market share in the hyperspectral imaging systems industry .

Canadian business leaders want better R&D support to strengthen productivity and the innovation economy

Retrieved on: 
수요일, 4월 10, 2024
Scientific method, IP, KPMG, ITC, Research, Business, Federation, Patent, Pressure, Government, Senior advisor, ED, Renewable energy

"Canadian businesses have faced challenges transforming ideas and innovations into viable, profitable ventures that spur economic growth and lead to a higher standard of living for Canadians.

Key Points: 
  • "Canadian businesses have faced challenges transforming ideas and innovations into viable, profitable ventures that spur economic growth and lead to a higher standard of living for Canadians.
  • Currently, there are tax incentives for early-stage R&D; however, widely available support to transition the resulting knowledge into commercialized patents is missing in Canada's approach."
  • "Business leaders also want more routine R&D that yields productivity improvements for their company to be made eligible under SR&ED, even if the tax credit rate is lower," adds Mr. Durst.
  • "The question becomes whether the federal government's review of innovation programs will support a broader range of R&D in Canada that may not be patentable, but directly improves business productivity."

Atamyo Therapeutics Obtains Regulatory Authorization in Europe to Initiate a Clinical Trial for ATA-200, its Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type 2C/R5

Retrieved on: 
화요일, 3월 26, 2024
Health, Genetics, Clinical Trials, Pharmaceutical, Cardiology, Biotechnology, CNRS, Neurology, AAV, Motivation, Environment, Scientific method, Patient, CTA, DSM-IV codes, Biomarker, Research, ANSM, University, EMA, European Medicines Agency, Clinical trial, Therapy, Muscular dystrophy, Safety, Pathology, Weakness, Cardiomyopathy, Pharmaceutical industry

This authorization was first granted by the Italian Medicines Agency (AIFA), then by the French Medicines Agency (ANSM).

Key Points: 
  • This authorization was first granted by the Italian Medicines Agency (AIFA), then by the French Medicines Agency (ANSM).
  • Giacomo Comi, Full Professor of Neurology at the University of Milan (Italy), and principal investigator of this trial.
  • ATA-200, a gene therapy candidate for LGMD2C/R5, delivers a normal copy of the gene for production of γ-sarcoglycan protein.
  • In addition to its LGMD2C/R5 gene therapy, Atamyo is developing a clinical trial with ATA-100 gene therapy for LGMD2I/R9, related to deficiencies in FKRP; and is in IND-enabling studies for LGMD2A/R1, related to deficiencies in calpain protein.

MitoRx Therapeutics Strengthens Scientific Advisory Board with Appointment of Four International Experts

Retrieved on: 
목요일, 3월 7, 2024
Therapy, CNRS, Target, Newcastle University, Facial muscles, Biotechnology, Professor, Teaching hospital, SAB, Neuromuscular disease, Ageing, Leiden University Medical Center, HD, DMD, Duchenne muscular dystrophy, Inflammation, LUMC, Mitochondrion, Gene therapy, Scientific method, Genetics, Knowledge, Leibniz Association, Publication, Translational research, Respiratory disease, Research, COPD, Pharmaceutical industry

OXFORD, United Kingdom, March 07, 2024 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the appointment of four distinguished international experts to its Scientific Advisory Board (SAB): Caroline Le Guiner PhD, Milos Filipovic PhD, Professor Phil Hansbro PhD, and Professor Annemieke Aartsma-Rus.

Key Points: 
  • OXFORD, United Kingdom, March 07, 2024 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the appointment of four distinguished international experts to its Scientific Advisory Board (SAB): Caroline Le Guiner PhD, Milos Filipovic PhD, Professor Phil Hansbro PhD, and Professor Annemieke Aartsma-Rus.
  • Dr. Jon Rees, Chief Executive Officer of MitoRx, said, “We are thrilled to welcome Dr.
  • Le Guiner, Dr. Filipovic, Professor Hansbro, and Professor Aartsma-Rus, to our Scientific Advisory Board.
  • She has a visiting professorship at the John Walton Muscular Dystrophy Research Center at the UK’s Newcastle University.